These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11689722)

  • 1. Role of invasive electrophysiologic testing in risk stratification for sudden cardiac death.
    Saeed M; Homoud MK; Wang PJ; Estes NA; Link MS
    J Invasive Cardiol; 2001 Nov; 13(11):758-62. PubMed ID: 11689722
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of invasive and noninvasive testing in risk stratification of sudden cardiac death in children and young adults: an electrophysiologic perspective.
    Attari M; Dhala A
    Pediatr Clin North Am; 2004 Oct; 51(5):1355-78. PubMed ID: 15331288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The athlete's heart: prevention of sudden cardiac death.
    Manshadi R
    Rev Cardiovasc Med; 2008; 9(4):259-60. PubMed ID: 19122583
    [No Abstract]   [Full Text] [Related]  

  • 5. Idiopathic dilated cardiomyopathy: prognostic significance of electrocardiographic and electrophysiologic findings in the nineties.
    Morgera T; Di Lenarda A; Sabbadini G; Rakar S; Carniel E; Driussi M; Sinagra G
    Ital Heart J; 2004 Aug; 5(8):593-603. PubMed ID: 15554030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sudden cardiac death in young men].
    Perings C; Schoebel FC; Hennersdorf M; Vester EG; Strauer BE
    Dtsch Med Wochenschr; 1996 Sep; 121(38):1169-75. PubMed ID: 8925738
    [No Abstract]   [Full Text] [Related]  

  • 7. Small coronary artery disease in cardiomyopathy: hypertrophic cardiomyopathy resembling dilated cardiomyopathy.
    Fujiwara H; Nishigaki K
    Coron Artery Dis; 1995 Mar; 6(3):213-9. PubMed ID: 7788033
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk stratification for arrhythmic events in patients with idiopathic dilated cardiomyopathy: a review of the literature and current perspectives.
    Calò L; Peichl P; Bulava A; Lamberti F; Loricchio ML; Castro A; Meo A; Pandozi C; Santini M
    Ital Heart J; 2003 Sep; 4(9):580-8. PubMed ID: 14635374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed hyperenhancement magnetic resonance imaging for sudden cardiac death risk stratification in hypertrophic cardiomyopathy.
    Efthimiadis GK; Pagourelias ED
    J Am Coll Cardiol; 2009 Dec; 55(1):77. PubMed ID: 20117370
    [No Abstract]   [Full Text] [Related]  

  • 10. Fatal potential of supraventricular tachycardia in hypertrophic cardiomyopathy.
    Munclinger MJ; Thornton AS; Schutte DP; Sliwa K
    Int J Cardiol; 2004 Feb; 93(2-3):335-7. PubMed ID: 14975578
    [No Abstract]   [Full Text] [Related]  

  • 11. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy.
    Maron BJ
    Circulation; 2010 Jan; 121(3):445-56. PubMed ID: 20100987
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy.
    Miller MA; Gomes JA; Fuster V
    Nat Clin Pract Cardiovasc Med; 2007 Dec; 4(12):667-76. PubMed ID: 18033231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiomyopathies and cardiac sudden death (discussion)].
    Nihon Naika Gakkai Zasshi; 1993 Feb; 82(2):246-59. PubMed ID: 8492029
    [No Abstract]   [Full Text] [Related]  

  • 14. The editor's roundtable: sudden cardiac death in athletes.
    Friedewald VE; Maron BJ; Roberts WC
    Am J Cardiol; 2007 Nov; 100(9):1451-9. PubMed ID: 17950807
    [No Abstract]   [Full Text] [Related]  

  • 15. Symptoms and management options in cardiomyopathy.
    Cruickhnak S; Mason N
    Nurs Times; 2005 Nov 8-14; 101(45):26-9. PubMed ID: 16312078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The quest for perfection: the contribution of the electrocardiogram to the prevention of sudden death in hypertrophic cardiomyopathy.
    O'Mahony C; Elliott P
    Europace; 2009 May; 11(5):548-9. PubMed ID: 19287015
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cardiovascular sudden death].
    Loire R
    Ann Pathol; 1999 Jun; 19(3):203-11. PubMed ID: 10456194
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetes does not affect ventricular repolarization and sudden cardiac death risk in patients with dilated cardiomyopathy.
    Vrtovec B; Fister M; Poglajen G; Starc V; Haddad F
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S146-50. PubMed ID: 19250080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identify the young athlete at risk for sudden cardiac death.
    Lipp LN
    JAAPA; 2001 Aug; 14(8):26-8, 31-2, 35-7. PubMed ID: 11556060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.